News By Tag
* Drug-disease Modeling
* PK models
* Muscular Dystrophy
* More Tags...
News By Place
Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012
PK/PD analyses used to support the rationale for therapeutic strategies targeting myostatin pathway
"We are pleased to have Pfizer present these results from our collaboration. This work clearly demonstrates the importance and impact of incorporating pharmacometrics and modeling into the drug development process," said Dr. Toufigh Gordi, President, PK/PD and Clinical Pharmacology Services
Rosa informs our customer’s most critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of related issues, Rosa offers two customized approaches: classic pharmacokinetic/
Rosa and the Rosa logo are registered trademarks of Rosa & Co. LLC.
# # #
Rosa creates robust mathematical models that simulate drug effects and trial outcomes. Modeling and Simulation complement traditional experimental methods, enabling unique insights that streamline drug development and regulatory interactions.